Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response

Mutations in the Epidermal growth factor receptor (EGFR) kinase domain, such as the L858R missense mutation and deletions spanning the conserved sequence (747)LREA(750), are sensitive to tyrosine kinase inhibitors (TKIs). The gatekeeper site residue mutation, T790M accounts for around 60% of acquire...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Cell Proteomics
Päätekijät: Zhang, Xu, Maity, Tapan, Kashyap, Manoj K., Bansal, Mukesh, Venugopalan, Abhilash, Singh, Sahib, Awasthi, Shivangi, Marimuthu, Arivusudar, Charles Jacob, Harrys Kishore, Belkina, Natalya, Pitts, Stephanie, Cultraro, Constance M., Gao, Shaojian, Kirkali, Guldal, Biswas, Romi, Chaerkady, Raghothama, Califano, Andrea, Pandey, Akhilesh, Guha, Udayan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The American Society for Biochemistry and Molecular Biology 2017
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5417828/
https://ncbi.nlm.nih.gov/pubmed/28331001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/mcp.M117.067439
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia